I spoke with leaders from Senseonics and Sequel MedTech to unpack a major first in diabetes tech—the integration of the Eversense 365 implantable continuous glucose monitor with the twiist insulin pump for automated insulin delivery. We explore how this implantable CGM works, what makes it different from traditional sensors, and how the new looping system connects through dual apps to support a more automated diabetes management experience. We break down usability, accuracy, weekly calibrations, alert customization, and early feedback from the first users trying the system. We also look ahead at next-generation implantable CGMs, upcoming app upgrades, and future insulin pump innovations that could further reshape automated insulin delivery for people living with diabetes.

Learn about Omnipod 5 (today's sponsor)*

Learn about the Eversense 365 CGM

Join the Diabetech Newsletter

Follow Diabetech: Instagram | Tik Tok | YouTube | Facebook | Threads

DISCLAIMER: This podcast is not medical advice and is for educational purposes only. Always consult with your doctor before making changes to your health care. 

*10-day trial eligibility may vary. Full terms and conditions apply. Visit omnipod.com/diabetech for clinical disclaimers, terms and important safety information. The Pod has an IP28 rating for up to 25 feet for 60 minutes. The Omnipod 5 Controller is not waterproof.